Update on stress ulcer prophylaxis in critically ill patients.
Spirt
Mitchell J
MJ
Division of Gastroenterology, University of California, Los Angeles School of Medicine, Los Angeles, California, USA.
Stanley
Sandra
S
D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness / Q000451:nursing; D016903:Drug Monitoring / Q000451:nursing; D005753:Gastric Mucosa / Q000098:blood supply; D017442:Histamine Agonists / Q000627:therapeutic use; D006801:Humans; D007511:Ischemia / Q000150:complications / Q000175:diagnosis; D024802:Nurse's Role; D009730:Nursing Assessment; D010437:Peptic Ulcer / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D010438:Peptic Ulcer Hemorrhage / Q000209:etiology / Q000517:prevention & control; D054328:Proton Pump Inhibitors; D012121:Respiration, Artificial / Q000009:adverse effects; D012131:Respiratory Insufficiency / Q000150:complications / Q000628:therapy; D012307:Risk Factors; D013312:Stress, Physiological / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*
D000863:Antacids; D000897:Anti-Ulcer Agents; D017442:Histamine Agonists; D054328:Proton Pump Inhibitors